Dopaminergic Modulation of Frontostriatal Function With a Dopamine Agonist and COMT Inhibitor
Condition(s):AddictionLast Updated:November 16, 2021Withdrawn
Hide Studies Not Open or Pending
Condition(s):AddictionLast Updated:November 16, 2021Withdrawn
Condition(s):Parkinson’s Disease With Wearing-off Motor FluctuationsLast Updated:October 15, 2018Completed
Condition(s):Parkinson’s Disease (PD)Last Updated:July 15, 2016Completed
Condition(s):Parkinson’s DiseaseLast Updated:April 5, 2018Completed
Condition(s):Parkinson’s DiseaseLast Updated:January 14, 2016Completed
Condition(s):Parkinson Disease; Sleep DisordersLast Updated:July 13, 2016Unknown status
Condition(s):Parkinson’s DiseaseLast Updated:November 18, 2015Completed
Condition(s):Parkinson’s Disease (PD)Last Updated:September 20, 2016Completed
Condition(s):Parkinson’s Disease (PD)Last Updated:August 17, 2015Completed
Condition(s):Parkinson’s Disease (PD)Last Updated:January 21, 2015Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.